Litigation Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)
✉ Email this page to a colleague
Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-07-07 |
| Court | District Court, D. Delaware | Date Terminated | 2017-04-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | ACTAVIS INC. | ||
| Patents | 8,007,826; 8,354,437; 8,440,703; 8,663,685 | ||
| Attorneys | Cindy Ahn | ||
| Firms | Phillips, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Acorda Therapeutics Inc. v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 0000-00-00 | 1 | Actavis for patent infringement of United States Patent Nos. 8,007,826 (the “’826 patent”), 8,354,437…alleging that the ’826 patent, the ’437 patent, the ’703 patent, and the ’685 patent are “invalid, unenforceable…expiration of the ’826 patent, the ’437 patent, the ’703 patent and the ’685 patent.” Case 1:14-cV-00882…8,354,437 (the “’437 patent”), 8,440,703 (the “’703 patent”) and 8,663,685 (the “’685 patent”) (collectively,…for the ’826 patent as May 26, 2027, the ’437 patent as December 22, 2026, the ’703 patent as April 8, | External link to document | |
| 2016-03-16 | 195 | Book-listed patents: U.S. Patent Nos. 5,540,938 (the '" 938 patent"), 8,007,826 (the '…quot; 703 patent"), and 8,663, 685 (the '" 685 patent"). The asserted patents relate…x27;" 826 patent"), 8,354,437 (the '"437 patent"), 8,440,703 (the '"…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification | External link to document | |
| 2016-09-01 | 254 | United States Patent No. 5,540,938 (the “’938 patent”), United States Patent No. 8,007,826 (the “’826 …826 patent”), United States Patent No. 8,354,437 (the “’437 patent”), United States Patent No. 8,400,703…8,400,703 (the “’703 patent”), and United States Patent No. 8,663,685 (the “’685 patent”) (collectively the…the ’437 patent; claims 36, 38, and 45 of the ’703 patent; and claims 3 and 5 of the ’685 patent (collectively…claims 3 and 8 of the ’938 patent; claims 1, 7, 38, and 39 of the ’826 patent; claims 1, 2, 5, 22, 32, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
